All In MedTech

FDA Clearance Tracker · P190006-S024

Axonics Sacral Neuromodulation System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: May 19, 2021 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

May 19, 2021

Approved

Time to decision

218 days

Received Oct 13, 2020. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P190006-S024
Device name
Axonics Sacral Neuromodulation System
Applicant location
Marlborough, MA
Received
Oct 13, 2020
Decided
May 19, 2021
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P190006

Device type

Device class
Class III
Regulation
21 CFR 876.5270

Every decision under product code QON

FDA's approval statement

As written in FDA's record.

Approval for 1.5T and 3T MRI RF Extremity Coil Conditional Labeling on the Axonics Sacral Neuromodulation System.

Source documents

Other decisions for Boston Scientific Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.